Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of Calgary

$25,000.00

Development of an application to quantify clinically relevant metalloproteins in human blood plasma********

FY 2018-19

Summary
Blood plasma can be easily obtained and analyzed for proteins to obtain useful diagnostic information about the health status of an individual. The difficulty that is inherently associated with the analysis of plasma is that it contains thousands of proteins. This problem, however, can be dramatically simplified if it can be analyzed for metalloproteins, which represent a sub-group of proteins that contain bound metals. The development of a method that can be used to determine all metal-containing proteins in plasma therefore requires their separation and their detection by means of appropriate metal-specific detectors. To this end, Dr. Gailer's group has developed a size exclusion chromatography (SEC)-based separation method for the direct analysis of blood plasma for the contained iron, copper and zinc-containing metalloproteins, which are detected by means of an inductively coupled plasma atomic emission spectrometer (ICP-AES). This method employs a 30 cm x 1.0 cm SEC column, requires 0.5 mL/analysis and requires 25 min, which is not attractive for clinical biochemistry labs. The miniaturization of this method would significantly decrease the amount of plasma needed for analysis and reduce the overall analysis time. The separation can be accomplished with a smaller SEC column (15 cm x 0.5 cm) and the iron-containing proteins may be detected by means of a graphite furnace atomic absorption spectrometer (GFAAS). Since Lumex Instruments manufactures a GFAAS instrument, Dr. Gailer will develop a SEC-GFAAS system for the rapid analysis of human blood plasma for clinically relevant iron metalloproteins. This hyphenated technique has the potential to open new markets for this Canadian instrument manufacturer since capability of the proposed SEC-GFAAS system to rapidly and specifically quantify iron-containing proteins in human plasma is attractive for clinical biochemistry laboratories. *
Program
Engage Grants Program
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
537264-2018
Name nom
Gailer, Juergen
Department département
Chemistry
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
3505
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Analytical spectroscopy
Research subject fr
Spectroscopie analytique
Partie
1
Nb partie
1
Application title
Development of an application to quantify clinically relevant metalloproteins in human blood plasma********
Keyword
NSERC
Application summary
Blood plasma can be easily obtained and analyzed for proteins to obtain useful diagnostic information about the health status of an individual. The difficulty that is inherently associated with the analysis of plasma is that it contains thousands of proteins. This problem, however, can be dramatically simplified if it can be analyzed for metalloproteins, which represent a sub-group of proteins that contain bound metals. The development of a method that can be used to determine all metal-containing proteins in plasma therefore requires their separation and their detection by means of appropriate metal-specific detectors. To this end, Dr. Gailer's group has developed a size exclusion chromatography (SEC)-based separation method for the direct analysis of blood plasma for the contained iron, copper and zinc-containing metalloproteins, which are detected by means of an inductively coupled plasma atomic emission spectrometer (ICP-AES). This method employs a 30 cm x 1.0 cm SEC column, requires 0.5 mL/analysis and requires 25 min, which is not attractive for clinical biochemistry labs. The miniaturization of this method would significantly decrease the amount of plasma needed for analysis and reduce the overall analysis time. The separation can be accomplished with a smaller SEC column (15 cm x 0.5 cm) and the iron-containing proteins may be detected by means of a graphite furnace atomic absorption spectrometer (GFAAS). Since Lumex Instruments manufactures a GFAAS instrument, Dr. Gailer will develop a SEC-GFAAS system for the rapid analysis of human blood plasma for clinically relevant iron metalloproteins. This hyphenated technique has the potential to open new markets for this Canadian instrument manufacturer since capability of the proposed SEC-GFAAS system to rapidly and specifically quantify iron-containing proteins in human plasma is attractive for clinical biochemistry laboratories. *